| mRNA |
lovastatin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |
| mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |
| mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.002 |
| mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.005 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.005 |
| mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.007 |
| mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.007 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.007 |